Plain-English reading on the vagus nerve, its science and how to look after it
Conditions

Understanding the Symptoms of Vagus Nerve Inflammation

A flat folk-art vector illustration of a human oesophagus with a spray of cornflowers, daisies and leaves to one side.


The vagus nerve can become inflamed through the same mechanisms that affect any peripheral nerve — viral invasion, autoimmune attack, compression, or metabolic damage — but the consequences are uniquely widespread because no other peripheral nerve innervates so many organs. Vagal inflammation disrupts the parasympathetic brake on the heart, the motor drive to the gut, the anti-inflammatory reflex to the spleen, and the sensory feedback from virtually every abdominal and thoracic organ. The result is a pattern of dysfunction — tachycardia, gastroparesis, nausea, voice changes, and autonomic instability — that often gets attributed to anxiety or functional illness because no single organ appears damaged on standard testing.

What Vagal Inflammation Actually Means

Vagus nerve inflammation, clinically termed vagal neuritis or vagal neuropathy, refers to inflammatory damage to the nerve fibres, their myelin sheaths, or the ganglia (nodose and jugular) where vagal sensory neuron cell bodies reside. The inflammation can be localised to one segment of the nerve or diffuse across its entire length.

The vagus nerve contains approximately 80,000 fibres, roughly 80 percent of which are afferent (sensory). This means inflammation primarily disrupts the brain’s ability to receive information from the organs, not just the brain’s ability to send commands to them. The resulting symptoms reflect both the loss of motor output (slower gut motility, impaired swallowing, heart rate dysregulation) and the disruption of sensory input (visceral pain, nausea, interoceptive abnormalities).

Crucially, vagal inflammation is different from general vagus nerve dysfunction. Low vagal tone from chronic stress, deconditioning, or metabolic syndrome reflects reduced functional output of an intact nerve. Vagal neuritis involves actual structural damage — demyelination, axonal degeneration, or ganglionitis — that impairs the nerve’s physical capacity to transmit signals.

Post-Viral Vagal Neuropathy

The most common trigger for vagal inflammation is viral infection. Post-viral vagal neuropathy has been documented following influenza, Epstein-Barr virus (EBV), herpes simplex virus, cytomegalovirus, and most recently SARS-CoV-2.

COVID-19 brought vagal neuropathy to clinical attention at an unprecedented scale. Multiple research groups demonstrated direct evidence of vagal involvement in long COVID. Ultrasound studies, particularly from Italian research teams, found measurable changes in vagus nerve morphology in long COVID patients — including altered cross-sectional area and echogenicity of the cervical vagus nerve compared to recovered controls. These structural changes correlated with autonomic symptoms including resting tachycardia, gastroparesis, and orthostatic intolerance.

Autopsy and biopsy studies identified SARS-CoV-2 viral proteins within vagal sensory ganglia (the nodose ganglion), confirming that the virus can directly invade vagal neurons. The virus enters through ACE2 receptors, which are expressed on vagal afferent neurons in the gut and airways — the same neurons that normally detect inflammation and microbial products. This direct neurotropism distinguishes COVID-related vagal neuropathy from simple post-infectious inflammation: the virus attacks the nerve itself, not just the tissues around it.

The clinical presentation of post-COVID vagal neuropathy typically includes persistent tachycardia at rest (loss of vagal cardiac brake), gastroparesis or severe nausea (loss of vagal gastric motor drive), exercise intolerance with exaggerated heart rate responses, orthostatic symptoms overlapping with postural orthostatic tachycardia syndrome (POTS), and voice changes or dysphagia when the recurrent laryngeal branch is affected. Many of these symptoms overlap with what is broadly labelled “long COVID autonomic dysfunction.”

Other viruses produce similar patterns. EBV-related vagal neuropathy is well-documented and may contribute to the chronic fatigue and autonomic dysfunction seen in post-infectious mononucleosis. Influenza-associated vagal neuritis can present as acute gastroparesis weeks after the acute infection resolves — the so-called “post-viral gastroparesis” that gastroenterologists encounter regularly.

Your local vagus nerve experts

Find a vagus nerve practitioner near you

Our directory lists 2,684 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.

Or browse by approach

The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.

Autoimmune Vagal Neuropathy

The immune system can attack the vagus nerve directly through autoantibodies or T-cell mediated inflammation. The most clearly defined condition is autoimmune autonomic ganglionopathy (AAG), caused by antibodies against the ganglionic nicotinic acetylcholine receptor (specifically the alpha-3 subunit). These antibodies disrupt synaptic transmission in autonomic ganglia, including the vagal ganglia, producing widespread autonomic failure.

AAG presents with a combination of severe orthostatic hypotension, anhidrosis (inability to sweat), gastrointestinal dysmotility, urinary retention, and pupillary abnormalities. When the vagal component predominates, gastroparesis and intestinal pseudo-obstruction are often the most debilitating features. AAG can be diagnosed through serum testing for ganglionic AChR antibodies, though seronegative forms exist.

Beyond AAG, several systemic autoimmune conditions are associated with vagal inflammation. Sjogren’s syndrome produces small-fibre and autonomic neuropathy in roughly 20 percent of patients, and vagal involvement manifests as dry mouth (loss of vagally mediated salivary stimulation), gastroparesis, and reduced HRV. Systemic lupus erythematosus (SLE) can cause vasculitic neuropathy affecting the vagus nerve. Sarcoidosis, which produces granulomatous inflammation in neural tissue, can involve the vagus nerve directly, particularly at the cervical segment.

Paraneoplastic syndromes — immune responses triggered by cancers — can also target the vagus nerve. Anti-Hu antibodies (associated with small cell lung cancer) attack neurons throughout the autonomic nervous system, including vagal ganglia, producing severe gastrointestinal dysmotility that may precede cancer diagnosis by months.

How Vagal Inflammation Is Identified

Diagnosing vagal inflammation requires demonstrating both that the vagus nerve is dysfunctional and that inflammation is the cause — two separate questions that use different tools.

Autonomic function testing establishes whether the vagus nerve is working properly. The heart rate deep breathing test (HRDB) measures the heart rate variation between deep inhalation and exhalation, a response driven entirely by vagal efferent fibres to the heart. A reduced response (less than 15 bpm variation in young adults, adjusted for age) indicates impaired cardiac vagal function. The Valsalva manoeuvre ratio, tilt table testing, and thermoregulatory sweat testing complete the autonomic evaluation. These tests are available at most neurology practices with autonomic laboratories.

Vagus nerve ultrasound is an emerging diagnostic tool that directly visualises the nerve in the neck. In inflammatory conditions, the vagus nerve may appear swollen (increased cross-sectional area) during acute inflammation or atrophied (decreased cross-sectional area) in chronic neuropathy. While reference ranges are still being standardised, ultrasound provides a non-invasive way to assess structural changes that correlate with functional impairment.

Laboratory testing targets the underlying cause. Ganglionic AChR antibodies for AAG, anti-Hu and anti-CV2 antibodies for paraneoplastic syndromes, SSA/SSB antibodies for Sjogren’s, ACE levels and chest imaging for sarcoidosis, and inflammatory markers (ESR, CRP) for active inflammation. Post-viral cases may show elevated inflammatory markers during the acute phase but often normalise by the time chronic symptoms develop.

HRV monitoring using validated wearable devices provides a longitudinal view of vagal function. Overnight RMSSD trending over weeks can reveal gradual improvement or deterioration in vagal output, supplementing the snapshot provided by formal autonomic testing.

Distinguishing Vagal Inflammation from Functional Vagal Dysfunction

The critical clinical distinction is between structural vagal damage (neuritis/neuropathy) and functional vagal suppression (low vagal tone from stress, deconditioning, or metabolic factors). Both produce overlapping symptoms — tachycardia, GI dysmotility, reduced HRV — but they have different causes, different trajectories, and different treatments.

Structural vagal neuropathy typically has a definable onset (often following an infection or coinciding with an autoimmune flare), produces objective abnormalities on autonomic testing that remain consistent over time, and may show structural changes on nerve ultrasound. Recovery depends on nerve regeneration, which for the vagus nerve occurs slowly — peripheral nerve regeneration proceeds at approximately 1 mm per day, and given the vagus nerve’s length, full recovery from demyelinating injury can take months to years.

Functional vagal suppression develops gradually, fluctuates with stress levels and fitness, produces milder abnormalities on autonomic testing that improve with interventions like breathing training and exercise, and shows no structural nerve changes. Recovery is faster and more responsive to vagal-tone interventions like resonance frequency breathing, HRV biofeedback, and aerobic exercise.

The distinction matters for treatment. Structural vagal neuropathy may require immunotherapy (intravenous immunoglobulin, plasma exchange, or corticosteroids for autoimmune causes), antiviral treatment if caught early, or symptomatic management with prokinetic medications for gastroparesis and medications for tachycardia. Functional vagal suppression responds to the vagal-tone training techniques — breathing, exercise, stress management — that form the foundation of vagus nerve wellness practices. Many patients have elements of both, particularly in post-COVID presentations where initial viral damage is compounded by subsequent deconditioning and stress-related vagal suppression.

When to Seek Medical Evaluation

Vagal inflammation should be suspected when autonomic symptoms appear suddenly or subacutely (over days to weeks), particularly following a viral illness. Red flags that warrant urgent autonomic evaluation include unexplained resting tachycardia above 100 bpm that persists for weeks, new-onset gastroparesis (severe nausea, vomiting, early satiety, unintentional weight loss), orthostatic intolerance with near-syncope or syncope, voice changes or swallowing difficulty without an ENT explanation, and any combination of these symptoms following a documented infection.

The appropriate starting point is a neurologist with autonomic expertise. Many academic medical centres now have dedicated autonomic disorders clinics, and post-COVID autonomic dysfunction has expanded access to formal autonomic testing at community neurology practices.

Vagus nerve inflammation is one of the most underrecognised causes of chronic autonomic symptoms. The My Vagus Nerve & Me eBook covers vagal anatomy, the mechanisms behind nerve damage and recovery, and evidence-based strategies for supporting vagal function. Get My Vagus Nerve & Me eBook and understand the nerve that connects your brain to every major organ system.